Navigation Links
22nd Annual International Congress on Endovascular Interventions Convenes in Scottsdale, Arizona
Date:2/9/2009

World Experts to Announce Late-Breaking Developments in Endovascular Treatments for Cardiovascular Diseases

PHOENIX, Feb. 9 /PRNewswire/ -- International Congress Foundation is pleased to present International Congress XXII on Endovascular Interventions, a global educational forum where leading cardiovascular specialists assemble to discuss the newest developments in endovascular therapies.

Hosted by Arizona Heart Institute and supported by Arizona Heart Foundation, International Congress XXII takes place February 8-12, 2009 at the Phoenician Resort in Scottsdale, Arizona. Throughout the week, the latest advances and breaking news on endovascular technologies and techniques are announced through a combination of peer-reviewed abstract presentations by an international faculty, spirited debates and panel discussions. Live-case demonstrations of complex interventions are also broadcast via high-definition satellite from Arizona Heart Hospital endovascular suites and cardiac catheterization laboratories and Arizona Heart Institute Translational Research Center.

"The emphasis on advanced endovascular techniques, many developed at Arizona Heart Institute, has been the hallmark of International Congress for 22 years," said Dr. Edward B. Diethrich, International Congress Chairman and Founder/Medical Director of Arizona Heart Institute and Arizona Heart Hospital. "This year is no exception, as the Power of Three--Arizona Heart Institute, Arizona Heart Hospital and Arizona Heart Foundation & Translational Research Center--continues to forge new frontiers in cardiovascular medicine in all areas of patient care, research and education," continued Diethrich. "Despite today's challenging economic climate, we are more dedicated than ever to delivering superior care to all patients, both locally and globally."

International Congress XXII on Endovascular Interventions is a significant source of breaking news on multiple topics related to cardiovascular surgery and minimally invasive intervention such as:

        Abdominal Aortic Aneurysm: New Devices, Tools, and Techniques
        Indications for Stand-Alone Thoracic Endografting, Open Surgery and
        Hybrid Techniques
        Carotid Artery Stenting: Unresolved Problems and Questions
        Controversies in the Treatment of Peripheral Vascular Diseases
        Endovenous Treatment Modalities
        New Directions in Cardiovascular Imaging
        Multidisciplinary Approaches to Managing Lower Extremity Pain
        Creative Endovascular Surgical and Wound Care Solutions for Limb
        Salvage
        Holistic Approaches which Complement Cardiovascular Medicine
        Cardiac Stem Cell Treatment of Heart Failure and Residual Myocardial
        Ischemia
        Cell Therapy for Peripheral Vascular Disease
        The Future of Regenerative Medicine and Biogenomics

Obtain the latest details on International Congress on Endovascular Interventions at www.endovascularcongress.org. For media inquiries, contact Maggie Cocco at (602)-707-3519, mcocco@azheart.com.


'/>"/>
SOURCE Arizona Heart Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
2. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
3. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
4. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
5. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
6. Annual flu shot cuts need for doctors visits, hospitalization among children
7. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
8. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
9. Chem Rx to Present at Bear Stearns 20th Annual Healthcare Conference
10. BioMarin to Present at the Bear Stearns 20th Annual Healthcare Conference
11. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: